Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tanya Singh

Postdoctoral Research Scientist

I started my career in neuroscience research by working in Prof. Pankaj Seth’s lab at the National Brain Research Centre in India, where I learned the reprogramming of blood cells into iPSCs and investigated miRNA-mediated mechanisms governing gene expression in iPSCs.

I moved to the UK for my doctoral studies (2017-2021) in Dr. Yasir Syed’s lab at the Neuroscience and Mental Health Innovation Institute (NMHII), Cardiff University. During my PhD, I delved into the iPSC-derived astrocytes and microglia, unraveling their significance in the progression of neuropsychiatric disorders mediated by the 1q21.1 CNV, a domain previously overshadowed by neuronal-centric research.

I hold my first post-doctoral tenure (2021-2024) with Prof. Zam Cader at NDCN, University of Oxford where I worked on development of 2D and 3D stem cell models to investigate the molecular mechanism of epileptogenesis in Tuberous Sclerosis Complex.

In 2024, I joined DPAG as a Postdoctoral Research Scientist at the Salman and Wade-Martins group, as part of the EU-funded CONNECT Project, where my research focus on elucidating cellular connectivity within the intricate context of neurodegenerative disorders. Embracing an interdisciplinary approach, my goal is to integrate microfluidics and patient-derived stem cells to develop brain organoid models, aiming to shed light on the Parkinson’s disease progression, unlock novel mechanistic insights and identify new therapeutic targets.